Generic Portal

— Research Explorer

Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

Research output: Contribution to journal › Article › Academic › peer-review

DOI

https://doi.org/10.1016/S0140-6736(22)02302-9
Final published version

Iain B. McInnes
Akihiko Asahina
Laura C. Coates
Robert Landewé
Joseph F. Merola
Christopher T. Ritchlin
Yoshiya Tanaka
Laure Gossec
Alice B. Gottlieb
Richard B. Warren
Barbara Ink
Deepak Assudani
Rajan Bajracharya
Vishvesh Shende
Jason Coarse
Philip J. Mease

Original language	English
Pages (from-to)	25-37
Number of pages	13
Journal	The Lancet
Volume	401
Issue number	10370
Early online date	2022
DOIs	https://doi.org/10.1016/S0140-6736(22)02302-9
Publication status	Published - 7 Jan 2023

ID: 28821850